Back

Prognostic implication of tolvaptan in acute heart failure patients with renal dysfunction - Insights from AQUAMARINE Study -

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Heart failure / LV dysfunction Prognosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Yuta Sudo

Soka Municipal Hospital, Soka (Japan)

49 More presentations in this session

Presentation thumbnail
Effect of baseline clinical characteristics on in-hospital mortality of elderly patients with acute heart failure
Doctor J. Parissis (Athens, GR)
Abstract
Presentation thumbnail
The performance of AHEAD score in an Asian cohort of acute heart failure with either preserved or reduced left ventricular systolic function
Doctor Y. Chen (Taipei, TW)
Abstract
Presentation thumbnail
Prognostic impact of ventricular arterial coupling in asymptomatic patients for heart failure
Doctor C. De Pasquale (Messina, IT)
Abstract Slides
Presentation thumbnail
Association between the degree of heart rate Reduction in acute heart failure patients and short and intermediate term mortality
Doctor K. Alhabib (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Comparative analysis of three prognostic scores in heart failure with reduced ejection fraction
Doctor P. Freitas (Carnaxide, PT)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Heart failure / LV dysfunction

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources